• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从囊性纤维化大鼠模型中洞察上皮-间质转化

Insights into epithelial-mesenchymal transition from cystic fibrosis rat models.

作者信息

Rout-Pitt Nathan, Boog Bernadette, McCarron Alexandra, Reyne Nicole, Parsons David, Donnelley Martin

机构信息

Robinson Research Institute, University of Adelaide, South Australia; Adelaide Medical School, University of Adelaide, South Australia; Department of Respiratory and Sleep Medicine, Women's and Children's Hospital, South Australia.

出版信息

J Cyst Fibros. 2025 Jan;24(1):149-156. doi: 10.1016/j.jcf.2024.09.003. Epub 2024 Sep 12.

DOI:10.1016/j.jcf.2024.09.003
PMID:39266334
Abstract

BACKGROUND

Molecular pathways contributing to Cystic Fibrosis pathogenesis remain poorly understood. Epithelial-mesenchymal transition (EMT) has been recently observed in CF lungs and certain CFTR mutation classes may be more susceptible than others. No investigations of EMT processes in CF animal models have been reported.

AIM

The aim of this study was to assess the expression of EMT-related markers in Phe508del and knockout (CFTR-KO) rat lung tissue and tracheal-derived basal epithelial stem cells, to determine whether CFTR dysfunction can produce an EMT state.

METHOD

The expression of EMT-related markers in lung tissue and cultured tracheal basal epithelial stem cells from wildtype (WT), Phe508del, and CFTR-KO rats were assessed using qPCR and Western blots. Cell responses were evaluated in the presence of Rho-associated protein kinase (ROCK) inhibitor Y27632, which blocks EMT-pathways, or after treatment with TGFβ1 to stimulate EMT.

RESULTS

Different gene expression profiles were observed between Phe508del and CFTR-KO rat models compared to wild type. There was lower expression of type 1 collagen in KO lungs and primary cell cultures, while Phe508del lungs and cells had higher expression, particularly when treated with TGFβ1. The addition of Y27632 rescued changes in EMT related genes in Phe508del cells but not in KO cells.

CONCLUSION

Our findings show the first evidence of upregulated EMT pathways in the lungs and airway cells of any CF animal model. Differences in the regulation of the EMT genes and proteins in the Phe508del and CFTR-KO cells suggest that the signalling pathways underlying EMT are CFTR mutation dependent.

摘要

背景

导致囊性纤维化发病机制的分子途径仍未被充分了解。上皮-间质转化(EMT)最近在囊性纤维化肺部中被观察到,并且某些囊性纤维化跨膜传导调节因子(CFTR)突变类型可能比其他类型更易发生。目前尚未有关于囊性纤维化动物模型中EMT过程的研究报道。

目的

本研究旨在评估苯丙氨酸508缺失(Phe508del)和基因敲除(CFTR-KO)大鼠肺组织及气管来源的基底上皮干细胞中EMT相关标志物的表达,以确定CFTR功能障碍是否会导致EMT状态。

方法

使用定量聚合酶链反应(qPCR)和蛋白质免疫印迹法评估野生型(WT)、Phe508del和CFTR-KO大鼠肺组织及培养的气管基底上皮干细胞中EMT相关标志物的表达。在存在阻断EMT途径的Rho相关蛋白激酶(ROCK)抑制剂Y27632的情况下,或在用转化生长因子β1(TGFβ1)刺激EMT后,评估细胞反应。

结果

与野生型相比,Phe铲8del和CFTR-KO大鼠模型之间观察到不同的基因表达谱。在基因敲除肺组织和原代细胞培养物中,I型胶原表达较低,而Phe508del肺组织和细胞表达较高,尤其是在用TGFβ1处理时。添加Y27632可挽救Phe508del细胞中EMT相关基因的变化,但不能挽救基因敲除细胞中的变化。

结论

我们的研究结果首次证明了在任何囊性纤维化动物模型的肺和气道细胞中EMT途径上调。Phe508del和CFTR-KO细胞中EMT基因和蛋白质调节的差异表明,EMT潜在的信号通路依赖于CFTR突变。

相似文献

1
Insights into epithelial-mesenchymal transition from cystic fibrosis rat models.从囊性纤维化大鼠模型中洞察上皮-间质转化
J Cyst Fibros. 2025 Jan;24(1):149-156. doi: 10.1016/j.jcf.2024.09.003. Epub 2024 Sep 12.
2
Lentiviral vector gene therapy and CFTR modulators show comparable effectiveness in cystic fibrosis rat airway models.慢病毒载体基因治疗和 CFTR 调节剂在囊性纤维化大鼠气道模型中显示出相当的疗效。
Gene Ther. 2024 Nov;31(11-12):553-559. doi: 10.1038/s41434-024-00480-y. Epub 2024 Aug 25.
3
Mutant CFTR Drives TWIST1 mediated epithelial-mesenchymal transition.突变 CFTR 驱动 TWIST1 介导的上皮-间充质转化。
Cell Death Dis. 2020 Oct 26;11(10):920. doi: 10.1038/s41419-020-03119-z.
4
Impact of KLF4 on Cell Proliferation and Epithelial Differentiation in the Context of Cystic Fibrosis.KLF4 对囊性纤维化中细胞增殖和上皮分化的影响。
Int J Mol Sci. 2020 Sep 14;21(18):6717. doi: 10.3390/ijms21186717.
5
Evaluation of eluforsen, a novel RNA oligonucleotide for restoration of CFTR function in in vitro and murine models of p.Phe508del cystic fibrosis.评估新型 RNA 寡核苷酸 eluforsen 对体外和 p.Phe508del 囊性纤维化小鼠模型 CFTR 功能的恢复作用。
PLoS One. 2019 Jun 28;14(6):e0219182. doi: 10.1371/journal.pone.0219182. eCollection 2019.
6
The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis.组蛋白去乙酰化酶抑制剂伏立诺他不能挽救囊性纤维化中囊性纤维化跨膜传导调节因子的膜表达。
Int J Biochem Cell Biol. 2017 Jul;88:124-132. doi: 10.1016/j.biocel.2017.05.002. Epub 2017 May 3.
7
The Inhibition of the Membrane-Bound Transcription Factor Site-1 Protease (MBTP1) Alleviates the p.Phe508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Defects in Cystic Fibrosis Cells.膜结合型转录因子位点 1 蛋白酶(MBTP1)的抑制减轻了囊性纤维化跨膜电导调节因子(CFTR)p.Phe508del 缺陷型囊性纤维化细胞的缺陷。
Cells. 2024 Jan 18;13(2):185. doi: 10.3390/cells13020185.
8
The CF-modifying gene EHF promotes p.Phe508del-CFTR residual function by altering protein glycosylation and trafficking in epithelial cells.CF修饰基因EHF通过改变上皮细胞中的蛋白质糖基化和转运来促进p.Phe508del-CFTR残余功能。
Eur J Hum Genet. 2014 May;22(5):660-6. doi: 10.1038/ejhg.2013.209. Epub 2013 Oct 9.
9
Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.囊性纤维化基因修饰因子SLC26A9调节气道对CFTR靶向治疗的反应。
Hum Mol Genet. 2016 Oct 15;25(20):4590-4600. doi: 10.1093/hmg/ddw290.
10
Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.通过来自TNF-αR/NFκB信号通路的基因控制囊性纤维化肺上皮细胞中的促炎状态。
Mol Med. 2001 Aug;7(8):523-34.

引用本文的文献

1
CFTR ion transport deficiency primes the epithelium for partial epithelial-mesenchymal transition in cystic fibrosis.囊性纤维化跨膜传导调节因子(CFTR)离子转运缺陷使上皮细胞易于在囊性纤维化中发生部分上皮-间质转化。
Front Pharmacol. 2025 Aug 20;16:1655479. doi: 10.3389/fphar.2025.1655479. eCollection 2025.
2
Ontology-guided clustering enables proteomic analysis of rare pediatric disorders.本体引导的聚类分析可实现对罕见儿科疾病的蛋白质组学分析。
EMBO Mol Med. 2025 May 27. doi: 10.1038/s44321-025-00253-z.